Besponsa Injection, Powder, Lyophilized, For Solution
Product Images NDC 0008-0100

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Besponsa (NDC 0008-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Besponsa 01)

Chemical structure diagram of inotuzumab ozogamicin showing the antibody component labeled as Inotuzumab, a linker section, and the Calicheamicin moiety. The structure details the molecular components and connections within the drug conjugate.*

FDA Label Image

Figure 1 (Besponsa 02)

A Kaplan-Meier survival curve comparing survival probability over time (months) between Besponsa (inotuzumab ozogamicin) and Investigator's Choice of Chemotherapy. The graph shows higher survival probability for Besponsa. Below the curves, a table lists the number of patients at risk for each group at various time points up to 50 months.*

FDA Label Image

Pfizer Logo (Besponsa 03)

FDA Label Image

Principal Display Panel (0.9 mg Vial Label)

Label for Besponsa (inotuzumab ozogamicin) injection, powder, lyophilized, for solution, showing 0.9 mg per vial strength. It is for intravenous infusion only, single-dose vial with no preservatives, labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. Storage instructions specify refrigeration at 2° to 8°C and protection from light.*

FDA Label Image

Principal Display Panel (0.9 mg Vial Carton)

Carton packaging label for Besponsa (inotuzumab ozogamicin) for Injection, 0.9 mg/vial. The label indicates it is a powder, lyophilized, for solution injection intended for intravenous infusion only. Manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label includes usage instructions, storage conditions, and a single-dose vial designation, with prominent Pfizer branding and multiple barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.